ResMed Operating Margin 2010-2025 | RMD
Current and historical operating margin for ResMed (RMD) over the last 10 years. The current operating profit margin for ResMed as of March 31, 2025 is 26.66%.
| ResMed Operating Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Operating Income | Operating Margin |
| 2025-03-31 | $5.02B | $1.61B | 32.08% |
| 2024-12-31 | $4.93B | $1.56B | 31.66% |
| 2024-09-30 | $4.81B | $1.42B | 29.49% |
| 2024-06-30 | $4.69B | $1.32B | 28.18% |
| 2024-03-31 | $4.58B | $1.21B | 26.48% |
| 2023-12-31 | $4.50B | $1.14B | 25.31% |
| 2023-09-30 | $4.38B | $1.15B | 26.17% |
| 2023-06-30 | $4.22B | $1.13B | 26.81% |
| 2023-03-31 | $4.02B | $1.11B | 27.69% |
| 2022-12-31 | $3.76B | $1.05B | 27.76% |
| 2022-09-30 | $3.63B | $1.01B | 27.97% |
| 2022-06-30 | $3.58B | $1.00B | 27.94% |
| 2022-03-31 | $3.54B | $0.99B | 27.88% |
| 2021-12-31 | $3.44B | $0.98B | 28.34% |
| 2021-09-30 | $3.35B | $0.95B | 28.34% |
| 2021-06-30 | $3.20B | $0.90B | 28.28% |
| 2021-03-31 | $3.09B | $0.89B | 28.63% |
| 2020-12-31 | $3.09B | $0.88B | 28.47% |
| 2020-09-30 | $3.03B | $0.86B | 28.28% |
| 2020-06-30 | $2.96B | $0.81B | 27.40% |
| 2020-03-31 | $2.89B | $0.71B | 24.49% |
| 2019-12-31 | $2.78B | $0.65B | 23.24% |
| 2019-09-30 | $2.70B | $0.61B | 22.45% |
| 2019-06-30 | $2.61B | $0.58B | 22.22% |
| 2019-03-31 | $2.53B | $0.61B | 23.96% |
| 2018-12-31 | $2.46B | $0.58B | 23.79% |
| 2018-09-30 | $2.41B | $0.57B | 23.83% |
| 2018-06-30 | $2.34B | $0.54B | 23.15% |
| 2018-03-31 | $2.27B | $0.52B | 22.96% |
| 2017-12-31 | $2.20B | $0.49B | 22.45% |
| 2017-09-30 | $2.13B | $0.44B | 20.89% |
| 2017-06-30 | $2.07B | $0.43B | 20.57% |
| 2017-03-31 | $2.03B | $0.42B | 20.56% |
| 2016-12-31 | $1.97B | $0.41B | 21.04% |
| 2016-09-30 | $1.89B | $0.43B | 22.45% |
| 2016-06-30 | $1.84B | $0.43B | 23.32% |
| 2016-03-31 | $1.77B | $0.41B | 23.11% |
| 2015-12-31 | $1.74B | $0.41B | 23.65% |
| 2015-09-30 | $1.71B | $0.41B | 24.15% |
| 2015-06-30 | $1.68B | $0.41B | 24.43% |
| 2015-03-31 | $1.64B | $0.41B | 24.88% |
| 2014-12-31 | $1.62B | $0.41B | 25.19% |
| 2014-09-30 | $1.58B | $0.40B | 25.55% |
| 2014-06-30 | $1.56B | $0.41B | 26.05% |
| 2014-03-31 | $1.56B | $0.39B | 25.27% |
| 2013-12-31 | $1.54B | $0.38B | 24.92% |
| 2013-09-30 | $1.53B | $0.37B | 24.19% |
| 2013-06-30 | $1.52B | $0.35B | 23.35% |
| 2013-03-31 | $1.47B | $0.36B | 24.30% |
| 2012-12-31 | $1.44B | $0.34B | 23.57% |
| 2012-09-30 | $1.39B | $0.31B | 22.53% |
| 2012-06-30 | $1.37B | $0.30B | 21.55% |
| 2012-03-31 | $1.34B | $0.27B | 20.31% |
| 2011-12-31 | $1.30B | $0.26B | 19.88% |
| 2011-09-30 | $1.28B | $0.26B | 20.53% |
| 2011-06-30 | $1.24B | $0.27B | 21.48% |
| 2011-03-31 | $1.19B | $0.27B | 22.55% |
| 2010-12-31 | $1.16B | $0.27B | 22.95% |
| 2010-09-30 | $1.13B | $0.25B | 22.52% |
| 2010-06-30 | $1.09B | $0.24B | 22.05% |
| 2010-03-31 | $1.05B | $0.23B | 21.84% |
| 2009-12-31 | $1.00B | $0.22B | 22.16% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $37.534B | $4.685B |
| ResMed, Inc. holds a major position as designer, manufacturer, as well as a distributor in the worldwide market for generators, masks, and related accessories for the treatment of sleep-disordered breathing (SDB) and other respiratory disorders. SDB includes obstructive sleep apnea (OSA) and other respiratory disorders that occur during sleep. The company currently has two operating segments, which are the Sleep and Respiratory Care segment and the Software-as-a-Service segment. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $231.781B | 27.87 |
| Boston Scientific (BSX) | United States | $152.324B | 38.13 |
| Stryker (SYK) | United States | $149.641B | 31.29 |
| EssilorLuxottica (ESLOY) | France | $137.721B | 0.00 |
| Medtronic (MDT) | Ireland | $114.146B | 16.18 |
| Lonza Group Ag (LZAGY) | Switzerland | $51.237B | 0.00 |
| Haleon (HLN) | United Kingdom | $45.147B | 25.77 |
| GE HealthCare Technologies (GEHC) | United States | $34.575B | 16.42 |
| Agilent Technologies (A) | United States | $34.457B | 22.46 |
| Terumo (TRUMY) | Japan | $25.051B | 32.54 |
| Koninklijke Philips (PHG) | Netherlands | $23.235B | 16.30 |
| Insulet (PODD) | United States | $20.934B | 82.17 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.835B | 12.10 |
| Baxter (BAX) | United States | $15.298B | 11.42 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $13.441B | 0.00 |
| Demant (WILYY) | Denmark | $8.971B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $8.561B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $6.887B | 23.97 |
| Lantheus Holdings (LNTH) | United States | $5.776B | 14.57 |
| Prestige Consumer Healthcare (PBH) | United States | $3.897B | 17.41 |
| Perrigo (PRGO) | Ireland | $3.742B | 9.48 |
| Haemonetics (HAE) | United States | $3.724B | 16.96 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Envista Holdings (NVST) | United States | $3.454B | 28.70 |
| ICU Medical (ICUI) | United States | $3.341B | 24.63 |
| QuidelOrtho (QDEL) | United States | $2.135B | 14.68 |
| LeMaitre Vascular (LMAT) | United States | $1.910B | 42.70 |
| AtriCure (ATRC) | United States | $1.580B | 0.00 |
| Acuren (TIC) | United States | $1.397B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $1.272B | 16.26 |
| Green Thumb Industries (GTBIF) | United States | $1.249B | 28.09 |
| AdaptHealth (AHCO) | United States | $1.247B | 12.66 |
| Neogen (NEOG) | United States | $1.194B | 15.28 |
| BioLife Solutions (BLFS) | United States | $1.068B | 0.00 |
| InMode (INMD) | Israel | $0.963B | 9.70 |
| Kestra Medical Technologies (KMTS) | United States | $0.791B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.703B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.679B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.670B | 0.00 |
| Owens & Minor (OMI) | United States | $0.667B | 5.53 |
| Evolus (EOLS) | United States | $0.623B | 0.00 |
| CeriBell (CBLL) | United States | $0.596B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.522B | 0.00 |
| Valneva SE (VALN) | France | $0.502B | 0.00 |
| Surmodics (SRDX) | United States | $0.441B | 0.00 |
| SNDL (SNDL) | Canada | $0.373B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.347B | 12.77 |
| Sanuwave Health (SNWV) | United States | $0.308B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.304B | 0.00 |
| Quanterix (QTRX) | United States | $0.295B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.291B | 0.00 |
| Cerus (CERS) | United States | $0.285B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.276B | 23.27 |
| Sanara MedTech (SMTI) | United States | $0.269B | 0.00 |
| ZimVie (ZIMV) | United States | $0.264B | 12.01 |
| Aurora Cannabis (ACB) | Canada | $0.257B | 76.17 |
| Brainsway (BWAY) | Israel | $0.246B | 65.00 |
| Canopy Growth (CGC) | Canada | $0.232B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.227B | 0.00 |
| Biote (BTMD) | United States | $0.225B | 6.34 |
| Verano Holdings (VRNOF) | United States | $0.210B | 0.00 |
| Omeros (OMER) | United States | $0.198B | 0.00 |
| Organigram Global (OGI) | Canada | $0.193B | 0.00 |
| High Tide (HITI) | Canada | $0.190B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.190B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.186B | 15.15 |
| Vireo Growth (VREOF) | United States | $0.150B | 0.00 |
| Exagen (XGN) | United States | $0.145B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.126B | 15.53 |
| TerrAscend (TSNDF) | Canada | $0.104B | 0.00 |
| MacroGenics (MGNX) | United States | $0.100B | 0.00 |
| Fonar (FONR) | United States | $0.096B | 12.37 |
| Jin Medical (ZJYL) | China | $0.093B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.089B | 0.00 |
| Apyx Medical (APYX) | United States | $0.086B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.082B | 0.00 |
| Veru (VERU) | United States | $0.081B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.072B | 0.00 |
| Zynex (ZYXI) | United States | $0.072B | 0.00 |
| InterCure (INCR) | Israel | $0.072B | 0.00 |
| Agape ATP (ATPC) | $0.071B | 0.00 | |
| Cytosorbents (CTSO) | United States | $0.070B | 0.00 |
| ImmuCell (ICCC) | United States | $0.061B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.041B | 0.00 |
| Nephros (NEPH) | United States | $0.040B | 53.29 |
| Modular Medical (MODD) | United States | $0.039B | 0.00 |
| United-Guardian (UG) | United States | $0.037B | 12.82 |
| Safety Shot (SHOT) | United States | $0.033B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.021B | 0.00 |
| INLIF (INLF) | $0.016B | 0.00 | |
| IM Cannabis (IMCC) | Canada | $0.014B | 0.00 |
| Flora Growth (FLGC) | United States | $0.014B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.014B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.014B | 0.00 |
| Senestech (SNES) | United States | $0.011B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.009B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.007B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |